Jinling Pharmaceutical Company Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 701.603 million compared to CNY 513.804 million a year ago. Operating income was CNY 56.428 million compared to operating loss of CNY 30.688 million a year ago. Net income was CNY 34.999 million compared to net loss of CNY 27.613 million a year ago. Basic earnings per share from continuing operations was CNY 0.0694 compared to basic loss per share from continuing operations of CNY 0.0548 a year ago.